SEC Form 4 · accession 0001209191-16-117514
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aram S. Adourian
Officer — SVP & Chief Scientific Officer
Period of report
Apr 14, 2014
Accepted (ET)
May 4, 2016 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 14, 2014 | M | 12,000 | $0.90 | A | 40,036 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.90 | Apr 14, 2014 | M | 12,000 | D | — | Apr 15, 2014 | Common Stock | 12,000 | 16,036 | D |
Explanation of responses
- F1The reporting person paid cash for the exercise price. The share and exercise price figures in this report do not reflect the 1-for-4 reverse stock split of the issuer's common stock effected on July 8, 2015.
- F2All of the shares underlying this option were vested and the option expired on April 15, 2014.